Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review

TNM Classification of Malignant Tumours

Hermanek, P., & Sobin, L. H. (1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,073 · see citing works

An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

Austin, P. C. (2011) · Multivariate Behavioral Research · doi:10.1080/00273171.2011.568786 · Cited by 12,242 · see citing works

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452 · see citing works

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810 · see citing works

Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094 · see citing works

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712 · see citing works

TNM Classification of Malignant Tumors

Carter, D. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199810000-00016 · Cited by 6,354 · see citing works

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Psarelli, E. E., Valle, J. W., Halloran, C. M., Faluyi, O. O., O'Reilly, D. A., Cunningham, D., Wadsley, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32409-6 · Cited by 1,942 · see citing works

The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States

Bilimoria, K. Y., Stewart, A. K., Winchester, D. P., & Ko, C. Y. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9747-3 · Cited by 1,853 · see citing works

International Classification of Diseases for Oncology

Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,688 · see citing works

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib

Hammel, P. R., Huguet, F., Laethem, J. V., Goldstein, D., Glimelius, B. L. G., Artru, P., Borbath, I., Bouché, O., Shannon, J., André, T., et al. (2016) · JAMA · doi:10.1001/jama.2016.4324 · Cited by 1,092 · see citing works

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

Loehrer, P. J., Feng, Y., Cardenes, H. R., Wagner, L. I., Brell, J. M., Cella, D. F., Flynn, P. J., Ramanathan, R. K., Crane, C. H., Alberts, S. R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.8904 · Cited by 831 · see citing works

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

Chauffert, B., Mornex, F., Bonnetain, F., Rougier, P. R., Mariette, C., Bouché, O., Bosset, J.-F., Aparicio, T., Mineur, L., Azzedine, A., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn281 · Cited by 696 · see citing works

Treatment of Locally Unresectable Carcinoma of the Pancreas: Comparison of Combined-Modality Therapy (Chemotheraphy Plus Radiotherapy) to Chemotheraphy Alone1

Gastrointestinal Tumor Study Group (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.10.751 · Cited by 576 · see citing works

Pancreatic Adenocarcinoma, Version 2.2014

Tempero, M. A., Malafa, M. P., Behrman, S. W., Benson, A. B., Casper, E. S., Chiorean, E. G., Chung, V. M., Cohen, S. J., Czito, B. G., Engebretson, A., et al. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0106 · Cited by 464 · see citing works

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer

Koong, A. C., Le, Q., Ho, A., Fong, B. T., Fisher, G. A., Cho-Phan, C. D., Ford, J., Poen, J. C., Gibbs, I. C., Mehta, V. K., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.11.004 · Cited by 445 · see citing works

Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas

Chang, D. T., Schellenberg, D. D., Shen, J., Kim, J., Goodman, K. A., Fisher, G. A., Ford, J. M., Desser, T. S., Quon, A. S. W., & Koong, A. C. (2009) · Cancer · doi:10.1002/cncr.24059 · Cited by 378 · see citing works

Single-Fraction Stereotactic Body Radiation Therapy and Sequential Gemcitabine for the Treatment of Locally Advanced Pancreatic Cancer

Schellenberg, D. D., Kim, J., Christman-Skieller, C., Chun, C. L., Columbo, L. A., Ford, J. M., Fisher, G. A., Kunz, P. L., Dam, J. V., Quon, A. S. W., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.05.006 · Cited by 253 · see citing works

Overcoming drug resistance in pancreatic cancer

Long, J., Zhang, Y., Yu, X., Yang, J., LeBrun, D. G., Chen, C., Yao, Q. C., & Li, M. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.566216 · Cited by 239 · see citing works

Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy

Sultana, A., Smith, C. T., Cunningham, D., Starling, N., Tait, D., Neoptolemos, J. P., & Ghaneh, P. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603719 · Cited by 235 · see citing works

Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery

Nuttall, M., van der Meulen, J., & Emberton, M. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.07.015 · Cited by 219 · see citing works

Radiation therapy combined with adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma

Gastrointestinal Tumor Study Group (1985) · Cancer · doi:10.1002/1097-0142(19851201)56:11 · Cited by 172 · see citing works

Stereotactic Body Radiotherapy in the Treatment of Advanced Adenocarcinoma of the Pancreas

Rwigema, J.-C. M., Parikh, S. D., Heron, D. E., Howell, M., Zeh, H. J., Moser, A. J., Bahary, N., Quinn, A. E., & Burton, S. A. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181d270b4 · Cited by 165 · see citing works

The Secret of Immortal Time Bias in Epidemiologic Studies

Shariff, S. Z., Cuerden, M. S., Jain, A. K., & Garg, A. X. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121354 · Cited by 164 · see citing works

The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience

Moningi, S., Dholakia, A. S., Raman, S. P., Blackford, A. L., Cameron, J. L., Le, D. T., Jesus‐Acosta, A. D., Hacker‐Prietz, A., Rosati, L. M., Assadi, R. K., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4274-5 · Cited by 163 · see citing works

Smad4/DPC4 Silencing and Hyperactive Ras Jointly Disrupt Transforming Growth Factor-β Antiproliferative Responses in Colon Cancer Cells

Calonge, M. J., & Massagué, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33637 · Cited by 146 · see citing works

Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety

Gurka, M. K., Collins, S. P., Slack, R. S., Tse, G., Charabaty, A., Ley, L., Berzcel, L., Lei, S., Suy, S., Haddad, N., et al. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-44 · Cited by 125 · see citing works

Comparison of toxicity after IMRT and 3D-conformal radiotherapy for patients with pancreatic cancer – A systematic review

Bittner, M.-I., Grosu, A., & Brunner, T. B. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.11.043 · Cited by 91 · see citing works

Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma

Gurka, M. K., Kim, C. M., He, A. R., Charabaty, A., Haddad, N., Turocy, J. M., Johnson, L. B., Jackson, P. G., Weiner, L. M., Marshall, J. L., et al. (2014) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000118 · Cited by 68 · see citing works

Locally Advanced Pancreatic Cancer: The Role of Definitive Chemoradiotherapy

Huguet, F., Mukherjee, S., & Javle, M. M. (2014) · Clinical Oncology · doi:10.1016/j.clon.2014.06.002 · Cited by 54 · see citing works

Stereotactic body radiotherapy for the treatment of medically inoperable primary renal cell carcinoma: Current evidence and future directions

Swaminath, A., & Chu, W. (2015) · Canadian Urological Association Journal · doi:10.5489/cuaj.2900 · Cited by 29 · see citing works

A Meta-analysis of Randomized Clinical Trials of Chemoradiation Therapy in Locally Advanced Pancreatic Cancer

Ambe, C. M., Fulp, W. J., Springett, G. M., Hoffe, S. E., & Mahipal, A. (2015) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-015-9734-z · Cited by 20 · see citing works

Surgery for Localized Pancreatic Cancer

Strohl, M. P., Raigani, S., Ammori, J. B., Hardacre, J. M., & Kim, J. A. (2015) · Pancreas · doi:10.1097/mpa.0000000000000511 · Cited by 15 · see citing works

Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer

Yang, X., Lu, Y., Hang, J., Zhang, J., Zhang, T., Huo, Y., Liu, J., Lai, S., Luo, D., Wang, L., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0111 · Cited by 278 · see citing works

Artificial intelligence in pancreatic cancer

Huang, B., Huang, H., Zhang, S., Zhang, D., Shi, Q., Liu, J., & Guo, J. (2022) · Theranostics · doi:10.7150/thno.77949 · Cited by 142 · see citing works

Locally Advanced Pancreatic Cancer: A Review of Local Ablative Therapies

Ruarus, A. H., Vroomen, L. G. P. H., Puijk, R. S., Scheffer, H. J., & Meijerink, M. R. (2018) · Cancers · doi:10.3390/cancers10010016 · Cited by 87 · see citing works

Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT)

Oar, A. J., Lee, M., Le, H. V., Hruby, G., Dalfsen, R., Pryor, D. I., Lee, D., Chu, J., Holloway, L. C., Briggs, A., et al. (2019) · Practical Radiation Oncology · doi:10.1016/j.prro.2019.07.018 · Cited by 70 · see citing works

Stereotactic body radiation therapy for locally advanced pancreatic cancer

Jung, J., Yoon, S. M., Park, J., Seo, D., Lee, S. S., Kim, M.-H., Lee, S. K., Park, D. H., Song, T. J., Yoo, C., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214970 · Cited by 70 · see citing works

Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer

Hiroshima, Y., Fukumitsu, N., Saito, T., Numajiri, H., Murofushi, K. N., Ohnishi, K., Nonaka, T., Ishikawa, H., Okumura, T., & Sakurai, H. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.03.012 · Cited by 56 · see citing works

Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?

Bouchart, C., Navez, J., Closset, J., Hendlisz, A., Gestel, D. V., Moretti, L., & Laethem, J. V. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920936093 · Cited by 43 · see citing works

An Interpretable Planning Bot for Pancreas Stereotactic Body Radiation Therapy

Zhang, J., Wang, C., Sheng, Y., Palta, M., Czito, B., Willett, C., Zhang, J., Jensen, P. J., Yin, F.-F., Wu, Q., et al. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.10.019 · Cited by 41 · see citing works

Preclinical longitudinal imaging of tumor microvascular radiobiological response with functional optical coherence tomography

Demidov, V. V., Maeda, A., Sugita, M., Madge, V., Sadanand, S., Flueraru, C., & Vitkin, I. A. (2018) · Scientific Reports · doi:10.1038/s41598-017-18635-w · Cited by 39 · see citing works

Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis

Janssen, Q. P., van Dam, J. L., Kivits, I. G., Besselink, M. G., van Eijck, C. H. J., Homs, M. Y. V., Nuyttens, J. J. M. E., Qi, H., van Santvoort, H. C., Wei, A. C.-C., et al. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-10276-8 · Cited by 39 · see citing works

Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study

Janssen, Q. P., van Dam, J. L., Prakash, L. R., Doppenberg, D., Crane, C. H., van Eijck, C. H. J., Ellsworth, S. G., Jarnagin, W. R., O'Reilly, E. M., Paniccia, A., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.7008 · Cited by 36 · see citing works

Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome

Shin, T. J., Song, C., Jeong, C. W., Kwak, C. H., Seo, S., Kang, M., Chung, J., Hong, S., Hwang, E. C., Park, J. Y., et al. (2020) · Journal of Surgical Oncology · doi:10.1002/jso.26251 · Cited by 36 · see citing works

Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer—A Critical Review and Practical Consideration

Burkoň, P., Trna, J., Slavík, M., Němeček, R., Kazda, T., Pospíšil, P., Dastych, M., Eid, M., Novotný, I., Procházka, T., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10102480 · Cited by 33 · see citing works

Engineering Radiocatalytic Nanoliposomes with Hydrophobic Gold Nanoclusters for Radiotherapy Enhancement

Gutierrez, N. M. C., Clainche, T. L., Bulin, A., Leo, S., Kadri, M., Abdelhamid, A. G. A., Pujol‐Solé, N., Obaid, G., Hograindleur, M., Gardette, V., et al. (2024) · Advanced Materials · doi:10.1002/adma.202404605 · Cited by 33 · see citing works

Pancreatic cancer: treatment approaches and trends

Pereira, N. P., & Corrêa, J. R. (2018) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.13 · Cited by 33 · see citing works

Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer

Cui, J., Jiao, F., Li, Q., Wang, Z., Fu, D., Liang, J., Liang, H., Xia, T., Zhang, T., Zhang, Y., et al. (2022) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2022.08.006 · Cited by 32 · see citing works

Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma

Simoni, N., Micera, R., Paiella, S., Guariglia, S., Zivelonghi, E., Malleo, G., Rossi, G., Addari, L., Giuliani, T., Pollini, T., et al. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.06.019 · Cited by 28 · see citing works

AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer

Oar, A. J., Lee, M. A., Le, H. V., Wilson, K., Aiken, C., Chantrill, L. A., Simes, J. R., Nguyen, N. Q., Barbour, A. P., Samra, J. S., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08666-y · Cited by 28 · see citing works

S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL

Seufferlein, T. T. W., Mayerle, J. V., Böck, S., Brunner, T. B., Ettrich, T. J., Grenacher, L., Gress, T. M., Hackert, T., Heinemann, V., Kestler, A. M. R., et al. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1856-7346 · Cited by 27 · see citing works

Evaluation of the Visibility and Artifacts of 11 Common Fiducial Markers for Image Guided Stereotactic Body Radiation Therapy in the Abdomen

Slagowski, J. M., Colbert, L. E., Cazacu, I. M., Singh, B. S., Martin, R., Koay, E. J., Taniguchi, C. M., Koong, A. C., Bhutani, M. S., Herman, J. M., et al. (2020) · Practical Radiation Oncology · doi:10.1016/j.prro.2020.01.007 · Cited by 26 · see citing works

Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches

Committee of the Korean clinical practice guideline for pancreatic cancer and National Cancer Center, K. (2021) · Pancreatology · doi:10.1016/j.pan.2021.05.004 · Cited by 26 · see citing works

Adaptive MRI-guided stereotactic body radiation therapy for locally advanced pancreatic cancer – A phase II study

Ejlsmark, M. W., Bahij, R., Schytte, T., Hansen, C. R., Bertelsen, A. S., Mahmood, F., Mortensen, M. B., Detlefsen, S., Weber, B., Bernchou, U., et al. (2024) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2024.110347 · Cited by 25 · see citing works

Pancreatic cancer in young adults: changes, challenges, and solutions

Primavesi, F., Stättner, S., Schlick, K., Kiesslich, T., Mayr, C., Klieser, E., Urbas, R., & Neureiter, D. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s176700 · Cited by 24 · see citing works

Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case‐control study (PAULA‐1)

ARCELLI, A., Buwenge, M., Macchia, G., Bertini, F., Guido, A., Deodato, F., Cilla, S., Scotti, V., Rosetto, M. E., Djan, I., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3330 · Cited by 24 · see citing works

Increasing cancer permeability by photodynamic priming: from microenvironment to mechanotransduction signaling

Gutierrez, N. M. C., Pujol‐Solé, N., Arifi, Q., Coll, J., Clainche, T. L., & Broekgaarden, M. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10064-0 · Cited by 24 · see citing works

Recent advances in the management of pancreatic adenocarcinoma

Karakaş, Y., Laçin, Ş., & Yalçın, Ş. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1403319 · Cited by 24 · see citing works

Neoadjuvant stereotactic body radiation therapy for nonmetastatic pancreatic adenocarcinoma

Jiang, W., Haque, W. M., Verma, V., Butler, E. B., & Teh, B. S. (2019) · Acta Oncologica · doi:10.1080/0284186x.2019.1631472 · Cited by 21 · see citing works

Dosimetric Uncertainties Resulting From Interfractional Anatomic Variations for Patients Receiving Pancreas Stereotactic Body Radiation Therapy and Cone Beam Computed Tomography Image Guidance

Niedzielski, J. S., Liu, Y., Ng, S. S. W., Martin, R., Perles, L. A., Beddar, S. A., Rebueno, N. C. S., Koay, E. J., Taniguchi, C. M., Holliday, E. B., et al. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.08.002 · Cited by 20 · see citing works

Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation

Manderlier, M., Navez, J., Hein, M., Engelholm, J.-L., Closset, J., Bali, M. A., Gestel, D. V., Moretti, L., Laethem, J. V., & Bouchart, C. (2022) · Cancers · doi:10.3390/cancers14235730 · Cited by 20 · see citing works

Multiagent Chemotherapy and Stereotactic Body Radiation Therapy in Patients with Unresectable Pancreatic Adenocarcinoma: A Prospective Nonrandomized Controlled Trial

Hill, C., Rosati, L. M., Wang, H., Tsai, H., He, J. P., Hacker‐Prietz, A., Laheru, D. A., Zheng, L., Sehgal, S., Bernard, V., et al. (2022) · Practical Radiation Oncology · doi:10.1016/j.prro.2022.02.009 · Cited by 19 · see citing works

Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar

Mazzarotto, R., Simoni, N., Guariglia, S., Rossi, G., Micera, R., Robertis, R. D., Pierelli, A., Zivelonghi, E., Malleo, G., Paiella, S., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.600940 · Cited by 19 · see citing works

Volumetric tumor delineation and assessment of its early response to radiotherapy with optical coherence tomography

Demidov, V. V., Demidova, N., Pires, L., Demidova, O., Flueraru, C., Wilson, B. C., & Vitkin, I. A. (2021) · Biomedical Optics Express · doi:10.1364/boe.424045 · Cited by 19 · see citing works

Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma—A Critical Review of Randomised Trials

Ejlsmark, M. W., Schytte, T., Bernchou, U., Bahij, R., Weber, B., Mortensen, M. B., & Pfeiffer, P. (2023) · Current Oncology · doi:10.3390/curroncol30070499 · Cited by 18 · see citing works

New Frontiers in Pancreatic Cancer Management: Current Treatment Options and the Emerging Role of Neoadjuvant Therapy

Dallavalle, S., Campagnoli, G., Pastena, P., Martinino, A., Schiliró, D., & Giovinazzo, F. (2024) · Medicina · doi:10.3390/medicina60071070 · Cited by 18 · see citing works

Extracellular Vesicle-Loaded Oncogenic lncRNA NEAT1 from Adipose-Derived Mesenchymal Stem Cells Confers Gemcitabine Resistance in Pancreatic Cancer via miR-491-5p/Snail/SOCS3 Axis

Wu, R., Su, Z., Le, Z., Pei, R., Ding, Y., Li, D., Zhu, S., Xu, L., Zhao, W., & Zhou, W. (2023) · Stem Cells International · doi:10.1155/2023/6510571 · Cited by 17 · see citing works

EUS-guided placement of fiducial markers for the treatment of pancreatic cancer

Coronel, E. S., Singh, B. S., Cazacu, I. M., Moningi, S., Romero, L. G., Taniguchi, C. M., Herman, J. M., & Bhutani, M. S. (2019) · VideoGIE · doi:10.1016/j.vgie.2019.05.007 · Cited by 17 · see citing works

Pain Relief after Stereotactic Radiotherapy of Pancreatic Adenocarcinoma: An Updated Systematic Review

Buwenge, M., ARCELLI, A., Cellini, F., Deodato, F., Macchia, G., Cilla, S., Galietta, E., Strigari, L., Malizia, C., Cammelli, S., et al. (2022) · Current Oncology · doi:10.3390/curroncol29040214 · Cited by 17 · see citing works

Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia

Slotman, B. J., Clark, M. A., Özyar, E., Kim, M., Itami, J., Tallet, A. R., Debus, J., Pfeffer, R., Gentile, P., Hama, Y., et al. (2022) · Radiation Oncology · doi:10.1186/s13014-022-02114-2 · Cited by 16 · see citing works

Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments

Chuong, M. D., Clark, M. A., Henke, L. E., Kishan, A. U., Portelance, L., Parikh, P. J., Bassetti, M. F., Nagar, H., Rosenberg, S. A., Mehta, M. P., et al. (2022) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2022.11.013 · Cited by 16 · see citing works

Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation‑resistant pancreatic cancer

Kato, T., Matsuo, Y., Ueda, G., Murase, H., Aoyama, Y., Omi, K., Hayashi, Y., Imafuji, H., Saito, K., Morimoto, M., et al. (2022) · Oncology Reports · doi:10.3892/or.2022.8279 · Cited by 14 · see citing works

Endoscopic Ultrasound–Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Pancreatic Malignancy

Kim, S., & Shin, E. J. (2021) · Clinical Endoscopy · doi:10.5946/ce.2021.102 · Cited by 14 · see citing works

The Role of Radiation Therapy in the Older Patient

Dohm, A. E., Díaz, R., & Nanda, R. H. (2021) · Current Oncology Reports · doi:10.1007/s11912-020-01000-y · Cited by 13 · see citing works

Dosimetric impact of simulated changes in large bowel content during proton therapy with simultaneous integrated boost for locally advanced pancreatic cancer

Narita, Y., Katō, T., Takemasa, K., Sato, H., Ikeda, T., Harada, T., Oyama, S., & Murakami, M. (2021) · Journal of Applied Clinical Medical Physics · doi:10.1002/acm2.13429 · Cited by 13 · see citing works

Prolyl hydroxylase domain 3 influences the radiotherapy efficacy of pancreatic cancer cells by targeting hypoxia-inducible factor-1α

Tang, L., Wu, J., Cai, S., Huang, Y.-X., Zhang, X.-Q., Fu, W., Zhuang, Q., & Li, J. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s187615 · Cited by 13 · see citing works

Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer

Uchinami, Y., Kanehira, T., Fujita, Y., Miyamoto, N., Yokokawa, K., Koizumi, F., Shido, M., Takahashi, S., Otsuka, M., Yasuda, K., et al. (2023) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2023.100576 · Cited by 12 · see citing works

Nanoscintillator Coating: A Key Parameter That Strongly Impacts Internalization, Biocompatibility, and Therapeutic Efficacy in Pancreatic Cancer Models

FULBERT, C., Chaput, F., Stelse‐Masson, S., Henry, M., Chovelon, B., Bohic, S., Brückner, D., Garrevoet, J., Moriscot, C., Gallet, B., et al. (2024) · Small Science · doi:10.1002/smsc.202400041 · Cited by 11 · see citing works

Large database utilization in health outcomes research in pancreatic cancer: an update

Torgeson, A. M., Tao, R., Garrido‐Laguna, I., Willen, B. D., Le, A., & Lloyd, S. A. J. (2018) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2018.05.15 · Cited by 11 · see citing works

Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design

Doppenberg, D., Besselink, M. G., van Eijck, C. H. J., Intven, M., Koerkamp, B. G., Geert Kazemier, M., van Laarhoven, H. W. M., Meijerink, M. R., Molenaar, I. Q., Nuyttens, J. J. M. E., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-10419-4 · Cited by 10 · see citing works

Multifunctional exosome-driven pancreatic cancer diagnostics and therapeutics

Zhang, S., Li, D., Liu, Y., Qin, C., Tong, L., & Xu, L. (2023) · Extracellular Vesicle · doi:10.1016/j.vesic.2023.100022 · Cited by 10 · see citing works

Pancreatic Ductal Adenocarcinoma: Update of CT-Based Radiomics Applications in the Pre-Surgical Prediction of the Risk of Post-Operative Fistula, Resectability Status and Prognosis

Pacella, G., Brunese, M. C., D’Imperio, E., Rotondo, M., Scacchi, A., Carbone, M., & Guerra, G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12237380 · Cited by 10 · see citing works

Survival outcome after stereotactic body radiotherapy for locally advanced and borderline resectable pancreatic cancer: A systematic review and meta-analysis

Liu, S., Liu, Y., Yang, J., Santos, T. D., Yang, L., Li, M., Jiang, Q., & Ma, C. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101139 · Cited by 9 · see citing works

Stereotactic Body Radiation Therapy versus Concurrent Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Propensity Score-Matched Analysis

Shin, Y. S., Park, H. H., Park, J., Seo, D., Lee, S. S., Yoo, C., Kim, S., Yoon, S. M., Jung, J., Kim, M., et al. (2022) · Cancers · doi:10.3390/cancers14051166 · Cited by 9 · see citing works

Survival Outcomes and Failure Patterns in Patients with Inoperable Non-Metastatic Pancreatic Cancer Treated with Definitive Radiotherapy

Cao, B., Zhang, L., Wu, C.-C., Liu, X., Wang, Q., Tong, F., Yang, W., & Wang, J. (2023) · Cancers · doi:10.3390/cancers15082213 · Cited by 9 · see citing works

Global perspective on the genetic, epigenetic, and transcriptomic basis of gallbladder cancer

Das, D., Singh, P., Pal, M., Pandey, M., & Dixit, R. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104830 · Cited by 8 · see citing works

Comparative Effectiveness of Chemotherapy Alone Versus Radiotherapy-Based Regimens in Locally Advanced Pancreatic Cancer: A Real-World Multicenter Analysis (PAULA-1)

ARCELLI, A., Tarantino, G., Cellini, F., Buwenge, M., Macchia, G., Bertini, F., Guido, A., Deodato, F., Cilla, S., Scotti, V., et al. (2023) · Current Oncology · doi:10.3390/curroncol30060427 · Cited by 8 · see citing works

An Original Article for Assessment of Multimodality Imaging Based Precise Radiation Therapy (Rt) in the Management of Recurrent Pancreatic Cancers

Demiral, S. (2022) · Cancer therapy & Oncology International Journal · doi:10.19080/ctoij.2022.22.556078 · Cited by 8 · see citing works

Radiothérapie stéréotaxique : changement de monde ou effet de mode ?

Vallard, A., Vial, N., Jmour, O., Rehailia-Blanchard, A., Trone, J., Sotton, S., Daguenet, É., Guy, J., & Magné, N. (2019) · Bulletin du Cancer · doi:10.1016/j.bulcan.2019.09.011 · Cited by 8 · see citing works

Comparison of the dose escalation potential for two hypofractionated radiotherapy regimens for locally advanced pancreatic cancer

Bertholet, J., Hunt, A., Dunlop, A., Bird, T., Mitchell, A., Oelfke, U., Nill, S., & Aitken, K. L. (2019) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2019.03.001 · Cited by 8 · see citing works

Prognostic value of albumin-bilirubin score in pancreatic cancer patients after pancreatoduodenectomy with liver metastasis following radiofrequency ablation

Zhang, L., Zhang, X., Wu, B., Han, X. N., Guo, C., Li, B., Jing, H., & Cheng, W. M. (2023) · Pathology & Oncology Research · doi:10.3389/pore.2023.1611175 · Cited by 7 · see citing works

S3-Leitlinie Exokrines Pankreaskarzinom – Version 3.1

Seufferlein, T. T. W., Mayerle, J. V., Boeck, S. H., Brunner, T. B., Ettrich, T. J., Grenacher, L., Gress, T. M., Hackert, T., Heinemann, V., Kestler, A. M. R., et al. (2024) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2338-3533 · Cited by 7 · see citing works

Stomach and duodenum dose–volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in combination with chemotherapy

Broggi, S., Passoni, P., Tiberio, P., Cicchetti, A., Cattaneo, G. M., Longobardi, B., Mori, M., Reni, M., Slim, N., Vecchio, A. D., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.983984 · Cited by 7 · see citing works

Role of Neoadjuvant Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Adenocarcinoma—A Systematic Review and Meta-Analysis

Wu, H., Tsou, H., Lu, L., Lee, H.-L., Chiou, J. F., & Ch’ang, H.-J. (2025) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2025.02.037 · Cited by 6 · see citing works

Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort

Doppenberg, D., Lagerwaard, F. J., van Dieren, S., Meijerink, M. R., van der Vliet, H. J., Besselink, M. G., van Tienhoven, G., Versteijne, E., Slotman, B. J., Wilmink, J. W., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1149961 · Cited by 6 · see citing works

Ablative vs. Non-Ablative Radiotherapy in Palliating Locally Advanced Pancreatic Cancer: A Single Institution Experience and a Systematic Review of the Literature

Kamel, R., Dennis, K. E. B., Doody, J., & Pantarotto, J. R. (2023) · Cancers · doi:10.3390/cancers15113016 · Cited by 6 · see citing works

EUS-guided hydrogel injection to separate pancreatic head carcinoma from duodenum for enhanced radiotherapy: Multi-site feasibility study

Bhutani, M. S., Narang, A. K., Ding, K., Casey, B. W., Krishnan, K., Koay, E. J., Hong, T. S., Herman, J. M., Griffin, K. H., & Shin, E. J. (2024) · Endoscopy International Open · doi:10.1055/a-2286-1995 · Cited by 6 · see citing works

Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer

Moningi, S., Lei, X. J., Fang, P. Q., Taniguchi, C. M., Holliday, E. B., Koay, E. J., Koong, A. C., Ludmir, E. B., Minsky, B. D., Das, P., et al. (2022) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2022.04.007 · Cited by 6 · see citing works

Improvement of image quality for pancreatic cancer using deep learning-generated virtual monochromatic images: Comparison with single-energy computed tomography

Ohira, S., Koike, Y., Akino, Y., Kanayama, N., Wada, K., Ueda, Y., Masaoka, A., Washio, H., Miyazaki, M., Koizumi, M., et al. (2021) · Physica Medica · doi:10.1016/j.ejmp.2021.03.035 · Cited by 6 · see citing works

Radiotherapy for Locally Advanced Pancreatic Cancer in the Modern Era: A Systematic Review and Meta-Analysis

Bae, S. H., Jang, W. I., Yu, J. I., Park, H. C., Moon, J. E., Haustermans, K. M., Scorsetti, M., Høyer, M., & Kim, M. S. (2025) · Cancers · doi:10.3390/cancers17182959 · Cited by 5 · see citing works

Assessment of interfraction dose variation in pancreas SBRT using daily simulation MR images

Young, T., Lee, M. T., Johnston, M. L., Nguyen, T. P. T., Ko, R., & Arumugam, S. (2023) · Physical and Engineering Sciences in Medicine · doi:10.1007/s13246-023-01324-6 · Cited by 5 · see citing works

Survival outcomes of surgical and non-surgical treatment in elderly patients with stage I pancreatic cancer: A population-based analysis

Nie, D., Lan, Q., Shi, B., & Xu, F. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.958257 · Cited by 5 · see citing works

Induction FOLFIRINOX followed by stereotactic body radiation therapy in locally advanced pancreatic cancer

Jung, J. H., Song, C., Jung, I. H., Ahn, J., Kim, B., Jung, K., Lee, J.-C., Kim, J., & Hwang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1050070 · Cited by 5 · see citing works

Shear Wave Elastography Can Differentiate between Radiation-Responsive and Non-responsive Pancreatic Tumors: An ex Vivo Study with Murine Models

Wang, H., Mills, B. N., Mislati, R., Ahmed, R., Gerber, S. A., Linehan, D. C., & Doyley, M. M. (2019) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2019.10.005 · Cited by 5 · see citing works

Endoscopic ultrasound-guided fiducial marker placement for neoadjuvant chemoradiation therapy for resectable pancreatic cancer

Ashida, R., Fukutake, N., Takada, R., Ioka, T., Ohkawa, K., Katayama, K., Akita, H., Takahashi, H., Ohira, S., & Teshima, T. (2020) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i7.768 · Cited by 5 · see citing works

Stereotactic body radiation therapy for inoperable non-metastasized pancreatic adenocarcinoma: a randomised phase II study (TORPEDO).

Stas, D., Vandamme, T., Roeyen, G., Reynders, D., Demey, W., Stellamans, K., Bussels, B., Hutsebaut, I., Maurissen, I., Bouchart, C., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-15041-8 · Cited by 4 · see citing works

Stereotactic partial breast irradiation in primary breast cancer: A comprehensive review of the current status and future directions

Takanen, S., Pinnarò, P., Farina, I., Sperati, F., Botti, C., Vici, P., Soriani, A., Marucci, L., & Sanguineti, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.953810 · Cited by 4 · see citing works

The Trends and Outcomes of Initial Palliative Chemotherapy in Patients with Pancreatic Cancer in Korea Based on National Health Insurance Service Data

Jang, D. K., Kim, Y. A., Lee, J.-W., Kim, H., Lee, Y. S., Chun, J. W., Lee, J.-C., Woo, S. M., & Hwang, J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13113229 · Cited by 4 · see citing works

Hypofractionated intensity-modulated radiotherapy in locally advanced unresectable pancreatic cancer: A pilot study

Felice, F. D., Benevento, I., Bulzonetti, N., Shima, B., Rubini, F., Marampon, F., Musio, D., & Tombolini, V. (2019) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2019.04.003 · Cited by 4 · see citing works

Stereotactic Body Radiation Therapy and Ablative Therapies for Solid Tumors: Recent Advances and Clinical Applications

Zhu, J., Xu, Y., & Lu, X. (2019) · Technology in Cancer Research & Treatment · doi:10.1177/1533033819830720 · Cited by 4 · see citing works

Investigating the effects of stereotactic body radiation therapy on pancreatic tumor hypoxia and microvasculature in an orthotopic mouse model using intravital fluorescence microscopy

Samuel, T., Rapic, S., Lindsay, P. E., & DaCosta, R. S. (2024) · Scientific Reports · doi:10.1038/s41598-024-82757-1 · Cited by 3 · see citing works

All-component-active metal–organic frameworks for tailored chemoradiotherapy of self-defensive tumors

Xu, X., Yang, Z., Bao, S., Xu, Z., Liu, T., Wu, L., & Lei, J. (2025) · Chemical Science · doi:10.1039/d5sc02482j · Cited by 3 · see citing works

Anticancer Therapy Using FePt Nanoparticles Combined with Nanosecond Pulsed Electric Fields

Hu, S., Zhu, Y. Q., Cheng, P., Dai, G., Jin, L., Wang, Q., Chen, X., & Cai, C. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c03747 · Cited by 3 · see citing works

Dynamic detection of HER2 of circulating tumor cells in patients with gastric carcinoma and its clinical application

Zhao, H., Huang, C., Lin, M., Zhou, M., & Huang, C. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12703 · Cited by 3 · see citing works

Nestin Expression and the Survival of Patients With Digestive Tract Cancers: A Systematic Review and Meta-Analysis

Huang, L., Chen, L., Wang, Y., Zhang, F., Wang, T., Li, D., Wang, C., & Ma, H. (2023) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2023.22485 · Cited by 3 · see citing works

Prevention and treatment of digestive tract issues induced by postoperative adjuvant chemotherapy for pancreatic cancer using Terra Flava Usta.

Wu, T., & Jin, T. (2021) · PubMed Central · Cited by 3 · see citing works

Pancreatic SBRT on four modern platforms: dosimetric and radiobiological gains with the Ethos ring-gantry linac versus TrueBeam, Halcyon, and helical tomotherapy

Zhang, B., Kong, X., Zhang, G., Jiang, Z., & Dai, T. (2026) · Radiation Oncology · doi:10.1186/s13014-026-02812-1 · Cited by 2 · see citing works

Automatic stent recognition using perceptual attention U‐net for quantitative intrafraction motion monitoring in pancreatic cancer radiotherapy

He, X., Cai, W., Li, F., Zhang, P., Reyngold, M., Cuaron, J. J., Cerviño, L., Li, T., & Li, X. (2022) · Medical Physics · doi:10.1002/mp.15692 · Cited by 2 · see citing works

Effect of stomach size on organs at risk in pancreatic stereotactic body radiotherapy

Tanaka, O., Taniguchi, T., Adachi, K., Nakaya, S., Kiryu, T., Ukai, A., Makita, C., & Matsuo, M. (2022) · Radiation Oncology · doi:10.1186/s13014-022-02107-1 · Cited by 2 · see citing works

Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy

Kim, K., Park, H. C., Yu, J. I., Park, J. O., Hong, J. Y., Lee, K. T., Lee, K. H., Lee, J. K., Park, J. K., Heo, J. S., et al. (2024) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2024.100732 · Cited by 2 · see citing works

A single institution experience of the treatment of pancreatic ductal carcinoma: The demand and the role of radiation therapy

Kubo, K., Wadasaki, K., Komichi, D., Sasaki, T., Yamada, H., Matsugu, Y., Itamoto, T., Doi, M., & Shinozaki, K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0227305 · Cited by 2 · see citing works

The Role of Radio-Frequency and Stereotactic Ablation in the Treatment of Pancreatic Cancer

Iancu, I., Budusan, M., Capras, D., Odaini, A., Bocse, H., Herdean, A. I., Bolos, T., Breazu, C. M., Dogaru, I., Micu, C. M., et al. (2022) · Chirurgia · doi:10.21614/chirurgia.2759 · Cited by 2 · see citing works

Locally advanced pancreatic cancer successfully treated with high-dose helical tomotherapy

Hama, Y. (2018) · International Cancer Conference Journal · doi:10.1007/s13691-018-0340-3 · Cited by 2 · see citing works

Fiducial Placement for Guidance of Radiotherapy

Cazacu, I. M., Herman, J. M., & Bhutani, M. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-28964-5_12 · Cited by 2 · see citing works

Technical Innovations in the Delivery of Radiation Therapy

Hamilton, R. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-93084-4_63 · Cited by 1 · see citing works

Involved-Field Radiation Therapy for Patients With Unresectable Pancreatic Adenocarcinomas: Failure Pattern Analysis

Fogaroli, R. C., de Castro, D. G., Silva, M. L., Pellizzon, A. C. A., Gondim, G. R. M., Chen, M. J., Ramos, H., Neto, E. S., & Abrahão, C. H. (2023) · Cureus · doi:10.7759/cureus.48106 · Cited by 1 · see citing works

Association between chronic pancreatitis and pancreatic cancer at a central hospital in KwaZulu-Natal, South Africa

Madela, F., Sithole, M., Ntanzi, N., Chiliza, K., Kader, S., Mwazha, A., Thomson, S., & Aldous, C. M. (2024) · South African Journal of Surgery · doi:10.36303/sajs.00329 · Cited by 1 · see citing works

Temporal Validation of an FDG-PET-Radiomic Model for Distant-Relapse-Free-Survival After Radio-Chemotherapy for Pancreatic Adenocarcinoma

Vincenzi, M. D., Mori, M., Passoni, P., Tummineri, R., Slim, N., Midulla, M., Palazzo, G., Belardo, A., Spezi, E., Picchio, M., et al. (2025) · Cancers · doi:10.3390/cancers17061036 · Cited by 1 · see citing works

Interventional management of pancreatic cancer: Current strategies and future horizons

Wang, Y., Yan, R., Lü, J., Guo, J., & Teng, G. (2025) · Oncology and Translational Medicine · doi:10.1097/ot9.0000000000000097 · Cited by 1 · see citing works

Magnetic resonance-guided online adaptive stereotactic body radiotherapy for advanced inoperable pancreatic cancer: a prospective study

Chen, W., Wang, Z., Yu, L., Guan, Q., Dong, T., Hou, X., Xu, H., Zhang, Y., Jiang, F., Lian, X., et al. (2025) · Radiation Oncology · doi:10.1186/s13014-025-02776-8 · Cited by 1 · see citing works

Characteristics of a real-time radiation exposure dosimetry system using a synthetic ruby for radiotherapy

Matsumoto, K., Maruyama, A., Watanabe, S., Tachibana, R., Yamaguchi, T., Suzuki, K., Kurihara, Y., Maehara, M., Arakawa, S., & Hosokai, Y. (2022) · Radiological Physics and Technology · doi:10.1007/s12194-022-00691-1 · Cited by 1 · see citing works

Emerging Technologies for the Diagnosis and Treatment of Pancreatic Cancer

Swierczewska, M., Козлов, С. В., & Adiseshaiah, P. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811785-9.00022-3 · Cited by 1 · see citing works

Stereotactic body radiotherapy for locally-advanced unresectable pancreatic cancer—patterns of care and overall survival

Dohopolski, M. J., Glaser, S., Vargo, J. A., Balasubramani, G. K., & Beriwal, S. (2017) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2017.08.04 · Cited by 23 · see citing works

Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma

Gurka, M. K., Kim, C. M., He, A. R., Charabaty, A., Haddad, N., Turocy, J. M., Johnson, L. B., Jackson, P. G., Weiner, L. M., Marshall, J. L., et al. (2014) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000118 · Cited by 68 · see citing works

Outcomes and Costs of SBRT vs. Conventional Treatments for Unresectable Pancreas Adenocarcinoma

Fang, P. Q., Lei, X. J., Koong, A. C., Das, P., Koay, E. J., Giordano, S. H., & Smith, G. L. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.07.417

Stereotactic Body Radiotherapy (SBRT) in the Treatment of Locally-advanced, Recurrent, and Unresectable and Pancreatic Adenocarcinoma

Rwigema, J.-C. M., Parikh, S. D., Burton, S. A., Quinn, A. E., Bahary, N., Lembersky, B. C., Zeh, H. J., Stoller, R. G., Howell, M., & Heron, D. E. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.07.613

Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era

Jaoude, J. A., Thunshelle, C. P., Kouzy, R., Nguyen, N. D., Lin, D., Prakash, L., Bumanlag, I. M., Noticewala, S. S., Niedzielski, J. S., Beddar, S. A., et al. (2021) · Advances in Radiation Oncology · doi:10.1016/j.adro.2021.100763 · Cited by 28 · see citing works